Vaxxinity, Inc.
Self-amplifying RNA (saRNA) vaccine platform for infectious diseases
- Sector
- Biotech
- Headquarters
- DALLAS, TX
- Founded
- 2021
- Latest Form D
- $27M, Mar 2021
- Total capital
- $1.4B
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.4B
- 2 Form D · last Mar 2021
- 67 months since last filing
- Federal contracts
- $39K
- 1 award · Health and Human S
- Rank in Biotech#360 of 4373
- Granted patents
- 0
- 27 pending
Capital timeline
Latest events
- Federal contractHealth and Human S · Ubi SARS-COV-2 Elisa Kit (p/n 600900)$39K
- Private capital raisedForm D · SEC · 2nd filing$27M
- Private capital raisedForm D · SEC · 1st filing$1.4B
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Dakin SlossDirectorNamed in SEC Form D filings
- James ChuiDirectorNamed in SEC Form D filings
- Louis ReeseDirectorNamed in SEC Form D filings
- Mei Mei HuExecutive Officer, DirectorNamed in SEC Form D filings
- Peter DiamandisDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 27- PendingTau Peptide Immunogen ConstructsUSPTOApplication 18993912
- PendingMethods For The Prevention And Treatment Of SynucleinopathiesUSPTOApplication 18688196
- PendingMyostatin And Activin A Immunogens And Methods Of UseUSPTOApplication PCTUS2024055221
Show all 27 patent records
- Tau Peptide Immunogen ConstructsJul 30, 2026 · Application 18993912Pending
- Methods For The Prevention And Treatment Of SynucleinopathiesOct 31, 2024 · Application 18688196Pending
- Myostatin And Activin A Immunogens And Methods Of UseApplication PCTUS2024055221Pending
- Tau And Amyloid Beta Peptide Immunogen Compositions And Related MethodsApplication PCTUS2024011843Pending
- Peptide Immunogen Compositions And Uses ThereofApplication 63611633Pending
- Tau Peptide Immunogen ConstructsApplication PCTUS2023027832Pending
- Tau Peptide Immunogen Constructs And Related MethodsApplication 63453677Pending
- SARS-COV-2 Vaccine For The Prevention And Treatment Of Coronavirus Disease (COVID-19)Application PCTUS2023062262Pending
- Tau Peptide Immunogen Constructs And Related MethodsApplication 63481744Pending
- Method For The Prevention And Treatment Of Coronavirus DiseaseApplication PCTUS2022051557Pending
- Method For The Prevention And Treatment Of Coronavirus DiseaseApplication PCTUS2022047053Pending
- Methods For The Prevention And Treatment Of SynucleinopathiesApplication PCTUS2022075836Pending
- SARS-COV-2 Multitope Peptide/protein Vaccine For The Prevention And Treatment Of Coronavirus Disease, 2019 (COVID-19)Application PCTUS2022074904Pending
- Tau Peptide Immunogen ConstructsApplication 63393533Pending
- Tau Peptide Immunogen ConstructsApplication 63389241Pending
- SARS-COV-2 Vaccine For The Prevention And Treatment Of Coronavirus Disease (COVID-19)Application 63331620Pending
- SARS-COV-2 Vaccine For The Prevention And Treatment Of Coronavirus Disease (COVID-19)Application 63321599Pending
- SARS-COV-2 Vaccine For The Prevention And Treatment Of Coronavirus Disease (COVID-19)Application 63308832Pending
- SARS-COV-2 Vaccine For The Prevention And Treatment Of Coronavirus Disease (COVID-19)Application 63308463Pending
- SARS-CoV-2 MULTITOPE PEPTIDE/PROTEIN VACCINE FOR THE PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19)Application 63257544Pending
- Methods For The Prevention And Treatment Of SynucleinopathiesApplication 63239505Pending
- SARS-CoV-2 MULTITOPE PEPTIDE/PROTEIN VACCINE FOR THE PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19)Application 63237745Pending
- Novel SARS-CoV-2 Multitope Protein-Peptide Vaccine (UB-612) in healthy adults: A Phase 1, dose escalation studyApplication 63233232Pending
- Peptide Immunogen Compositions And Uses ThereofApplication 19598277Pending
- Tau And Amyloid Beta Peptide Immunogen Compositions And Related MethodsApplication 19151140Pending
- Method For The Prevention And Treatment Of Coronavirus DiseaseApplication 18702601Pending
- Peptide Immunogen Compositions And Uses ThereofApplication PCTUS2024060768Pending
Related companies, and why
- PUMA BIOTECHNOLOGY, INC.Similar federal contract value in Biotech · $47K in contracts
- Miromatrix Medical Inc.Similar federal contract value in Biotech · $46K in contracts
- BIOVINC, LLCSimilar federal contract value in Biotech · $45K in contracts
- CELL BIOLOGICS INCSimilar federal contract value in Biotech · $37K in contracts
- EPIGENOME TECHNOLOGIES, INC.Similar federal contract value in Biotech · $35K in contracts
- G-SPACE INCSimilar federal contract value in Biotech · $35K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .